Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-05-01 to 2025-05-02
Current total value of award: $21.42
Description: 4568101112!CLONAZEPAM 0.5 MG TABLET 100S